Viewing nowCombinationEgliptin XR Extended Release Tablet 50/1000 mg
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
(Co., Ltd.) BIVOCON Pharmaceutical

MFDS item code 202201937 · Approved 2022.05.11 · Insurance code 658204640
Improvement of blood sugar control in type 2 diabetes
This drug helps to assist blood sugar control in patients with type 2 diabetes by taking sitagliptin and metformin together. It is used for patients who are also on dietary and exercise therapy and helps to effectively improve blood sugar levels. This makes diabetes management smoother.
The drug 100/1000 mg extended release tablet should be taken once daily, one tablet at a time. Patients taking the 50/500 mg extended release tablet or the 50/1000 mg extended release tablet should take two tablets at once once daily. 1. Patients not currently treated with metformin: The starting dose consists of a total daily dosage of 100 mg of sitagliptin and 1000 mg of metformin. If sufficient blood sugar control is not achieved with the starting dose, further.
This drug contains two ingredients, sitagliptin and metformin, and is used for diabetes treatment. First, while taking this medication, severe allergic reactions may occur. If you experience symptoms such as rash, itching, difficulty breathing, or swelling of the face or neck, you should stop taking it immediately and inform your healthcare provider. In addition, serious inflammation of the pancreas known as acute pancreatitis may develop, so if symptoms such as abdominal pain, vomiting, or nausea occur, you should consult a doctor immediately. The metformin component of this medication can rarely cause life-threatening metabolic abnormalities known as lactic acidosis, so if you experience sudden fatigue, muscle pain, difficulty breathing, abdominal pain, or reduced consciousness, you must stop taking it immediately and seek emergency treatment. If you have impaired kidney function, using this medication can be risky. Regular kidney function tests should be performed, and if kidney function declines, you should stop taking it. This medication should not be used in patients with certain serious conditions, such as severe kidney impairment, acute heart failure, severe infections, dehydration, or in women who are pregnant or breastfeeding. While taking this medication, you should be cautious of hypoglycemic symptoms, especially when taken with other blood sugar-lowering agents, as this can lead to excessively low blood glucose levels; thus, symptoms should be closely monitored. Moreover, alcohol consumption can increase the risk of side effects associated with this medication, so excessive drinking should be avoided. If you have upcoming surgery, you should stop taking this medication at least 48 hours before the surgery and resume it only after confirming normal kidney function post-surgery. It is important to maintain regular meals and exercise while taking this medication and to manage your condition through regular blood sugar and kidney function tests. Finally, this medication is not recommended for use in children under 18 years of age or in pregnant or breastfeeding women since its safety has not been established.
Hives, severe swelling (angioedema), anaphylaxis, severe skin adverse reactions (rash, skin vasculitis, Stevens-Johnson syndrome, exfoliative dermatitis), acute pancreatitis, acute kidney failure, liver abnormalities (elevated liver enzymes, liver dysfunction), severe edema, hypoglycemia, lactic acidosis, severe allergic reactions, worsening of kidney function, severe hypoglycemia, severe arthralgia, bullous pemphigoid, severe headache, confusion, seizures, visual disturbances
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.
Bright green oval-shaped extended-release film-coated tablet with convex surfaces on both sides
28 tablets/bottle, 56 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
(Co., Ltd.) BIVOCON Pharmaceutical
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.